• Almeida, M., S. Iyer, M. Martin-Millan, S. M. Bartell, L. Han, E. Ambrogini, et al. 2013. Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual. J. Clin. Invest. 123:394404.
  • Barkhem, T., B. Carlsson, Y. Nilsson, E. Enmark, J. Gustafsson, S. Nilsson, et al. 1998. Differential response of estrogen receptor alpha and estrogen receptor beta to partial estrogen agonists/antagonists. Mol. Pharmacol. 54:105112.
  • Böttner, M., J. Christoffel, and W. Wuttke. 2008. Effects of long-term treatment with 8-prenylnaringenin and oral estradiol on the GH-IGF-1 axis and lipid metabolism in rats. J. Endocrinol. 1982:395401.
  • Bovee, T. F., R. J. Helsdingen, I. M. Rietjens, J. Keijer, and R. L. Hoogenboom. 2004. Rapid yeast estrogen bioassays stably expressing human estrogen receptors alpha and beta, andgreen fluorescent protein: a comparison of different compounds with both receptortypes. J. Steroid Biochem. Mol. Biol. 91:99109.
  • Brunelli, E., G. Pinton, F. Chianale, A. Graziani, G. Appendino, and L. Moro. 2009. 8-Prenylnaringenin inhibits epidermal growth factor-induced MCF-7 breast cancer cell proliferation by targeting phosphatidylinositol-3-OH kinase activity. J. Steroid Biochem. Mol. Biol. 113:163170.
  • Chadwick, L. R., G. F. Pauli, and N. R. Farnsworth. 2006. The pharmacognosy of Humulus lupulus L. (hops) with an emphasis on estrogenic properties. Phytomedicine 13:119131.
  • Effenberger, K. E., S. A. Johnsen, D. G. Monroe, T. C. Spelsberg and J. J. Westendorf. 2005. Regulation of osteoblastic phenotype and gene expression by hop-derived phytoestrogens. J. Steroid Biochem. Mol. Biol. 96:387399.
  • Heyerick, A., S. Vervarcke, H. Depypere, M. Bracke, and D. De Keukeleire. 2006. A first prospective, randomized, double-blind, placebo-controlled study on the use of a standardized hop extract to alleviate menopausal discomforts. Maturitas 54:164175.
  • Hu, R., W. Liu, H. Li, L. Yang, C. Chen, Z. Y. Xia, et al. 2011. A Runx2/miR-3960/miR-2861 regulatory feedback loop during mouse osteoblast differentiation. J. Biol. Chem. 286:1232812339.
  • Humpel, M., P. Isaksson, O. Schaefer, U. Kaufmann, P. Ciana, and A. Maggi. 2005. Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus. J. Steroid Biochem. Mol. Biol. 97:299305.
  • Keiler, A. M., O. Zierau, and G. Kretzschmar. 2013. Hop extracts and hop substances in treatment of menopausal complaints. Planta Med. 79:576579.
  • Khosla, S., M. J. Oursler, and D. G. Monroe. 2012. Estrogen and the skeleton. Trends Endocrinol. Metab. 23:576581.
  • Lagari, V. S. and S. Levis. 2012. Phytoestrogens for menopausal bone loss and climacteric symptoms. J. Steroid Biochem. Mol. Biol., 139:294301.
  • Li, H., H. Xie, W. Liu, R. Hu, B. Huang, Y. F. Tan, et al. 2009. A novel microRNA targeting HDAC5 regulates osteoblast differentiation in mice and contributes to primary osteoporosis in humans. J. Clin Invest. 119:36663677.
  • Milligan, S., J. Kalita, V. Pocock, A. Heyerick, L. De Cooman, H. Rong, et al. 2002. Oestrogenic activity of the hop phyto-oestrogen, 8-prenylnaringenin. Reproduction 123:235242.
  • Ming, L. G., B. F. Ge, M. G. Wang, and K. M. Chen. 2012. Comparison between 8-prenylnarigenin and narigenin concerning their activities on promotion of rat bone marrow stromal cells' osteogenic differentiation in vitro. Cell Prolif. 45:508515.
  • Ming, L. G., X. Lv, X. N. Ma, B. F. Ge, P. Zhang, P. Song, et al. 2013. The prenyl group contributes to activities of phytoestrogen 8-prenynaringenin in enhancing bone formation and inhibiting bone resorption in vitro. Endocrinology 154:12021214.
  • Paoletti, T., S. Fallarini, F. Gugliesi, A. Minassi, G. Appendino, G. Lombardi, et al. 2009. Anti-inflammatory and vascularprotective properties of 8-prenylapigenin. Eur. J. Pharmacol. 620:120130.
  • Patisaul, H. B., and W. Jefferson. 2010. The pros and cons of phytoestrogens. Front. Neuroendocrinol. 31:400419.
  • Pedrera-Zamorano, J. D., J. M. Lavado-Garcia, R. Roncero-Martin, J. F. Calderon-Garcia, T. Rodriguez-Dominguez, and M. L. Canal-Macias. 2009. Effect of beer drinking on ultrasound bone mass in women. Nutrition 25:10571063.
  • Roelens, F., N. Heldring, W. Dhooge, M. Bengtsson, F. Comhaire, J. A. Gustafsson, et al. 2006. Subtle side-chain modifications of the hop phytoestrogen 8-prenylnaringenin result in distinct agonist/antagonist activity profiles for estrogen receptors alpha and beta. J. Med. Chem. 49:73577365.
  • Santen, R. J., D. C. Allred, S. P. Ardoin, D. F. Archer, N. Boyd, G. D. Braunstein, et al. 2010. Postmenopausal hormone therapy: an Endocrine Society scientific statement. J. Clin. Endocrinol. Metab. 95:s1s66.
  • Schaefer, O., M. Hümpel, K. H. Fritzemeier, R. Bohlmann, and W. D. Schleuning. 2003. 8-Prenylnaringenin is a potent ERalpha selective phytoestrogen present in hops and beer. J. Steroid Biochem. Mol. Biol. 84:359360.
  • Sehmisch, S., F. Hammer, J. Christoffel, D. Seidlova-Wuttke, M. Tezval, W. Wuttke, et al. 2008. Comparison of the phytohormones genistein, resveratrol and 8-prenylnaringenin as agents for preventing osteoporosis. Planta Med. 74:794801.
  • Windahl, S. H., K. Hollberg, O. Vidal, J. A. Gustafsson, C. Ohlsson, G. Andersson, et al. 2001. Female estrogen receptor beta−/− mice are partially protected against age-related trabecular bone loss. J. Bone Miner. Res. 16:13881398.
  • Yasuda, H. 2006. Bone and bone related biochemical examinations. Bone and collagen related metabolites. Receptor activator of NF-kappaB ligand (RANKL).Clin. Calcium 16:964970.
  • Zanoli, P., and M. Zavatti. 2008. Pharmacognostic and pharmacological profile of Humulus lupulus L. J. Ethnopharmacol. 116:383396.